| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11239-007-0102-0 |
| P698 | PubMed publication ID | 17906917 |
| P2093 | author name string | Agnes Yuet Ying Lee | |
| P2860 | cites work | Prognosis of Cancers Associated with Venous Thromboembolism | Q57301047 |
| Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study | Q63753987 | ||
| The effects of unfractionated heparin on survival in patients with malignancy--a systematic review | Q73307814 | ||
| Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group | Q73649146 | ||
| The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis | Q77447843 | ||
| Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy | Q79825413 | ||
| Incidence of venous thromboembolism and its effect on survival among patients with common cancers | Q82676244 | ||
| Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer | Q28186303 | ||
| Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q28213383 | ||
| Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer | Q34120902 | ||
| Incidence of venous thromboembolism in patients hospitalized with cancer | Q34487253 | ||
| Improved cancer mortality with low-molecular-weight heparin treatment: a review of the evidence | Q34555507 | ||
| Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery | Q34561015 | ||
| Venous thromboembolism and cancer: risks and outcomes | Q35157800 | ||
| Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer | Q42605270 | ||
| Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. | Q43597590 | ||
| Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study | Q44086372 | ||
| Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). | Q44895898 | ||
| Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period | Q44988252 | ||
| A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer | Q45013436 | ||
| Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer | Q46378877 | ||
| Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. | Q46378893 | ||
| Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery | Q47206731 | ||
| Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial | Q47334024 | ||
| The effect of low molecular weight heparin on survival in patients with advanced malignancy | Q47392658 | ||
| Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis | Q49168732 | ||
| P433 | issue | 1 | |
| P921 | main subject | venous thromboembolism | Q9397786 |
| P304 | page(s) | 33-36 | |
| P577 | publication date | 2007-09-29 | |
| P1433 | published in | Journal of Thrombosis and Thrombolysis | Q15766541 |
| P1476 | title | Cancer and venous thromboembolism: prevention, treatment and survival | |
| P478 | volume | 25 |
| Q37532738 | Audit of anticoagulation after embolectomy for acute ischaemia. |
| Q37460063 | Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study |
| Q33392669 | Established Venous Thromboembolism Therapies: Heparin, Low Molecular Weight Heparins, and Vitamin K Antagonists, with a Discussion of Heparin-Induced Thrombocytopenia |
| Q37011663 | IVC filters may prevent fatal pulmonary embolism in musculoskeletal tumor surgery |
| Q48393708 | Prolonged postoperative venous thrombo-embolism prophylaxis is cost-effective in advanced ovarian cancer patients |
| Q37419797 | Unanswered questions in venous thromboembolism |
| Q37190522 | Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis |
Search more.